Kunadt, D., Zukunft, S., Röllig, C., Metzelder, S., Burchert, A., Wagner-Drouet, E., . . . Stölzel, F. (2026). Treatment sequence with gilteritinib and allogeneic haematopoietic stem cell transplantation in relapsed/refractory FMS-like tyrosine kinase 3 (FLT3)-mutated acute myeloid leukaemia patients: A multicentre real-world study : transplantation & cellular therapy. British journal of haematology. https://doi.org/10.1111/bjh.70735
Style de citation Chicago (17e éd.)Kunadt, Désirée, et al. "Treatment Sequence with Gilteritinib and Allogeneic Haematopoietic Stem Cell Transplantation in Relapsed/refractory FMS-like Tyrosine Kinase 3 (FLT3)-mutated Acute Myeloid Leukaemia Patients: A Multicentre Real-world Study : Transplantation & Cellular Therapy." British Journal of Haematology 2026. https://doi.org/10.1111/bjh.70735.
Style de citation MLA (9e éd.)Kunadt, Désirée, et al. "Treatment Sequence with Gilteritinib and Allogeneic Haematopoietic Stem Cell Transplantation in Relapsed/refractory FMS-like Tyrosine Kinase 3 (FLT3)-mutated Acute Myeloid Leukaemia Patients: A Multicentre Real-world Study : Transplantation & Cellular Therapy." British Journal of Haematology, 2026, https://doi.org/10.1111/bjh.70735.